Synopsis
Ascites is an abnormal accumulation of fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension.
The global Ascites Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ascites Treatment in various end use industries. The expanding demands from the Ambulatory Surgical Centers, Hospitals and Clinics,, are propelling Ascites Treatment market. Medicinal Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Paracentesis segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ascites Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ascites Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ascites Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ascites Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ascites Treatment covered in this report include Sequana Medical, BioVie, PharmaCyte Biotech, Fresenius, GI Supply and Medtronic, etc.
The global Ascites Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sequana Medical
BioVie
PharmaCyte Biotech
Fresenius
GI Supply
Medtronic
Global Ascites Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ascites Treatment market, Segment by Type:
Medicinal Therapy
Paracentesis
Liver Transplantation
Others
Global Ascites Treatment market, by Application
Ambulatory Surgical Centers
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Ascites Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Ascites Treatment
1.1 Ascites Treatment Market Overview
1.1.1 Ascites Treatment Product Scope
1.1.2 Ascites Treatment Market Status and Outlook
1.2 Global Ascites Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Ascites Treatment Market Size by Region (2018-2029)
1.4 Global Ascites Treatment Historic Market Size by Region (2018-2023)
1.5 Global Ascites Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Ascites Treatment Market Size (2018-2029)
1.6.1 North America Ascites Treatment Market Size (2018-2029)
1.6.2 Europe Ascites Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Ascites Treatment Market Size (2018-2029)
1.6.4 Latin America Ascites Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Ascites Treatment Market Size (2018-2029)
2 Ascites Treatment Market by Type
2.1 Introduction
2.1.1 Medicinal Therapy
2.1.2 Paracentesis
2.1.3 Liver Transplantation
2.1.4 Others
2.2 Global Ascites Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Ascites Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Ascites Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Ascites Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Ascites Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Ascites Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Ascites Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Ascites Treatment Revenue Breakdown by Type (2018-2029)
3 Ascites Treatment Market Overview by Application
3.1 Introduction
3.1.1 Ambulatory Surgical Centers
3.1.2 Hospitals
3.1.3 Clinics
3.2 Global Ascites Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Ascites Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Ascites Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Ascites Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Ascites Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Ascites Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Ascites Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Ascites Treatment Revenue Breakdown by Application (2018-2029)
4 Ascites Treatment Competition Analysis by Players
4.1 Global Ascites Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ascites Treatment as of 2022)
4.3 Date of Key Players Enter into Ascites Treatment Market
4.4 Global Top Players Ascites Treatment Headquarters and Area Served
4.5 Key Players Ascites Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Ascites Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sequana Medical
5.1.1 Sequana Medical Profile
5.1.2 Sequana Medical Main Business
5.1.3 Sequana Medical Ascites Treatment Products, Services and Solutions
5.1.4 Sequana Medical Ascites Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Sequana Medical Recent Developments
5.2 BioVie
5.2.1 BioVie Profile
5.2.2 BioVie Main Business
5.2.3 BioVie Ascites Treatment Products, Services and Solutions
5.2.4 BioVie Ascites Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 BioVie Recent Developments
5.3 PharmaCyte Biotech
5.3.1 PharmaCyte Biotech Profile
5.3.2 PharmaCyte Biotech Main Business
5.3.3 PharmaCyte Biotech Ascites Treatment Products, Services and Solutions
5.3.4 PharmaCyte Biotech Ascites Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Fresenius Recent Developments
5.4 Fresenius
5.4.1 Fresenius Profile
5.4.2 Fresenius Main Business
5.4.3 Fresenius Ascites Treatment Products, Services and Solutions
5.4.4 Fresenius Ascites Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Fresenius Recent Developments
5.5 GI Supply
5.5.1 GI Supply Profile
5.5.2 GI Supply Main Business
5.5.3 GI Supply Ascites Treatment Products, Services and Solutions
5.5.4 GI Supply Ascites Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 GI Supply Recent Developments
5.6 Medtronic
5.6.1 Medtronic Profile
5.6.2 Medtronic Main Business
5.6.3 Medtronic Ascites Treatment Products, Services and Solutions
5.6.4 Medtronic Ascites Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Medtronic Recent Developments
6 North America
6.1 North America Ascites Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Ascites Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Ascites Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Ascites Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Ascites Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Ascites Treatment Market Dynamics
11.1 Ascites Treatment Industry Trends
11.2 Ascites Treatment Market Drivers
11.3 Ascites Treatment Market Challenges
11.4 Ascites Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List